Echo's glucose monitoring device shows positive trial results

12/7/2011 | Reuters

Echo Therapeutics said its Symphony tCGM device demonstrated a high accuracy rating in monitoring blood glucose levels and reported no adverse events in a clinical trial involving 20 patients with type 1 or type 2 diabetes. According to the study, 94.4% of the more than 2,600 glucose readings gathered using the device were found to be clinically accurate.

View Full Article in:


Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park